How much funding has Nevro raised?

Nevro has raised $126.0M in total funding, most recently a Series C round.

Where is Nevro headquartered?

Nevro is headquartered in Redwood City, California, United States.

What industry is Nevro in?

Nevro operates in medical-devices, neuromodulation, Healthcare, Medical Devices.

Nevro

Q: Who are Nevro's investors?

Nevro's investors include Novo Holdings A/S, Johnson & Johnson Innovation, NEA, Covidien Ventures.

IPO

True innovation that transforms more lives

Public · Redwood City, United States · Founded 2006 · $126.0M raised

medical-devices

neuromodulation

Healthcare

Medical Devices

Headquarters: Redwood City, California
Employees: 1001–5000
Founded: 2006
Business Model: B2B
Website: nevro.com

Total Funding: $126.0M
Last Round: $48.0M Series CMar 2013
Rounds: 4
Type: Public

About

Nevro is a medical device company and creator of HFX, an evidence-based spinal cord stimulation system for chronic pain of the trunk and limbs. Its proprietary 10 kHz Therapy is the most studied SCS therapy in the market, providing significant pain relief without paresthesia. The HFX iQ system integrates AI-driven adaptive therapy with cloud data insights for personalized, long-term relief.

Summary

Nevro is a medical-devices company based in Redwood City, United States, founded in 2006. It has raised $126.0M in total across 4 rounds, most recently a $48.0M Series C round in Mar 2013. Investors include Novo Holdings A/S, Johnson & Johnson Innovation and NEA.